SCHEDULE: Susquehanna Affiliates Disclose 1.4% Stake in Medifast

G1 Execution Services, Susquehanna Fundamental Investments, and Susquehanna Securities collectively reported a 1.4% beneficial ownership in Medifast, Inc. as of December 31, 2025.

Summary

• G1 Execution Services, LLC, Susquehanna Fundamental Investments, LLC, and Susquehanna Securities, LLC (collectively, the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G regarding Medifast, Inc.
• The Reporting Persons beneficially own an aggregate of 148,944 shares of Medifast, Inc. common stock.
• This aggregate ownership represents 1.4% of Medifast, Inc.'s outstanding common stock, based on 10,991,273 shares outstanding as of October 27, 2025.
• The beneficial ownership includes options to buy 139,300 shares held by Susquehanna Securities, LLC.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Medifast, Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral disclosure, as a Schedule 13G primarily reports a passive ownership stake and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings provide transparency into significant passive ownership stakes by institutional investors, which can signal long-term interest in a company without implying an intent to influence management or control.

Stakeholder Impact

• Shareholders: Provides transparency regarding institutional ownership, potentially signaling confidence from a large investment group.

Key Dates

Keywords

Medifast, G1 Execution Services, Susquehanna Fundamental Investments, Susquehanna Securities, beneficial ownership, Schedule 13G, common stock, institutional ownership, equity stake